Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
about
Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules.Molecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeuticsPhase 1 study of combination treatment with PTK 787/ZK 222584 and cetuximab for patients with advanced solid tumors: safety, pharmacokinetics, pharmacodynamics analysis.Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancerA phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumorsMET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.Potential of casein kinase I in digestive cancer screening.Protein kinase C and cancer: what we know and what we do not.Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells
P2860
Q27851721-E90425CA-4A92-45DB-AA9D-18450BB12A7CQ28544659-4E10101B-757A-4AE4-A002-ACDFB7ED6DA9Q33622614-1C8A7D4D-9C7D-4AEB-BC02-E34E82FA7D17Q34192330-BA5FCEA3-D72A-478A-BE48-5F032BD6D5ACQ35076220-4DE7F13E-9F04-4D82-B13A-A4FF1BB4313EQ35854826-D3B18948-C9A7-49DD-9964-C2D61F3A2CCCQ37470505-8927CC88-2E02-4805-BF82-1999A18FA4D3Q37821260-A35BCC10-E56D-44CA-8CBF-4C8BF9CFAD72Q38171231-B45D36EF-1D76-44F3-881B-76024D09E76AQ42290027-DA27B979-81B8-44B7-9072-C42790C188A1
P2860
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@en
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@nl
type
label
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@en
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@nl
prefLabel
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@en
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@nl
P2093
P2860
P356
P1476
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
@en
P2093
F Ciardiello
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604493
P407
P577
2008-08-01T00:00:00Z
P5875
P6179
1023783898